Canine Hemangiosarcoma: Treatment, Survival, Costs, and Clinical Trials in 2026
By Brycen Levings | Editor: Tariq Shah · July 16, 2026
The Cancer That Arrives as an Emergency
Few canine cancer diagnoses land as hard as hemangiosarcoma. It often announces itself with a sudden collapse — a tumor in the spleen ruptures, causing internal bleeding — and families are asked to make decisions within hours. It's an aggressive cancer of the cells that line blood vessels, and it's precisely because standard treatment has such a stubborn ceiling that trials are so important here. Pet Trial Finder currently tracks 16 trials across accredited U.S. veterinary teaching hospitals. This guide covers the forms of the disease, what treatment realistically offers, and the research trying to change the numbers.
What Is Canine Hemangiosarcoma?
Hemangiosarcoma (HSA) arises from the cells that form blood vessels, so it can develop almost anywhere — but it favors organs with a rich blood supply. Because these tumors are essentially malformed blood vessels, they bleed, and that bleeding often drives the emergency that brings a dog in.
The Forms of Hemangiosarcoma
Splenic hemangiosarcoma is the most common form, frequently discovered when the tumor ruptures and causes abdominal bleeding, prompting emergency surgery. Cardiac hemangiosarcoma develops in the heart (usually the right atrium), causing fluid around the heart; surgery is rarely possible, so treatment leans on drainage, chemotherapy, and sometimes radiation. Hepatic and pulmonary hemangiosarcoma, involving the liver or lungs, is often part of advanced disease. Cutaneous and subcutaneous hemangiosarcoma is the skin form — and when it's confined to the surface of the skin, the outlook is far better and surgery alone may be curative, an important exception to the disease's grim reputation. Deeper (subcutaneous) tumors behave more aggressively.
Standard Treatment and What It Costs
Emergency splenectomy removes the bleeding tumor and stabilizes the dog, at $2,500 to $6,000, often on an urgent basis. Doxorubicin-based chemotherapy is the standard follow-up aimed at the spread that's almost always already present, at $3,000 to $5,000. For the cardiac form, pericardial drainage and palliative care are variable in cost. Wide surgical excision for the cutaneous form runs $800 to $3,000. Here is the honest picture families deserve. For splenic hemangiosarcoma, surgery alone gives a median survival of only about 1 to 3 months, because microscopic spread is already underway. Adding doxorubicin chemotherapy extends median survival to roughly 4 to 6 months, and about 10 to 15% of dogs are alive at one year. The cutaneous, skin-confined form is the bright exception, with much longer survival after surgery. Those splenic numbers are sobering — and they are the single biggest reason to look seriously at a trial.
Clinical Trials: What Is Being Studied
Targeted toxin therapy such as eBAT — a bispecific agent designed to attack both tumor cells and the blood vessels feeding them — is one of the most promising hemangiosarcoma-specific approaches to emerge from veterinary research. Immunotherapy strategies aim to mobilize the immune system against residual disease after surgery. Metronomic chemotherapy uses continuous low-dose oral chemo to suppress micrometastasis with fewer side effects and lower cost. And repurposed or adjunct agents — beta-blockers such as propranolol, mushroom-derived polysaccharides, and maintenance targeted therapy (toceranib) — are studied for their ability to slow progression.
Who Qualifies for a Hemangiosarcoma Trial?
Because hemangiosarcoma moves fast, timing is everything. Most trials want a confirmed diagnosis, recent staging (chest and abdominal imaging, often an echocardiogram), and adequate organ function. Many enroll dogs immediately after splenectomy, in the window before chemotherapy would normally begin — so it pays to ask about trials at the time of surgery, not weeks later. Both post-surgical and relapsed dogs are represented.
How Trial Costs Compare to Standard Treatment
Fully funded trials typically cover the investigational agent, trial-specific imaging, and specialist monitoring — a real offset against the cost of surgery plus a full chemotherapy course. More to the point, trials are where the therapies aimed at hemangiosarcoma's brutal ceiling actually live. Pet Trial Finder checks your dog against all 16 trials — plus the full database of 133 trials across 39 cancer types — in a single application. Results in hours, not weeks.